These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4744861)

  • 21. Methotrexate analogs. 6. Replacement of glutamic acid by various amino acid esters and amines.
    Chaykovsky M; Brown BL; Modest EJ
    J Med Chem; 1975 Sep; 18(9):909-12. PubMed ID: 808614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active-site directed irreversible inhibitors of dihydrofolate reductase.
    Baker BR
    Ann N Y Acad Sci; 1971 Nov; 186():214-26. PubMed ID: 4943574
    [No Abstract]   [Full Text] [Related]  

  • 23. Amethopterin-induced changes in the multiple forms of dihydrofolate reductase from L1210 cells.
    Harding NG; Martelli MF; Huennekens FM
    Arch Biochem Biophys; 1970 Mar; 137(1):295-6. PubMed ID: 5435066
    [No Abstract]   [Full Text] [Related]  

  • 24. Further evaluation of the antitumor activity of homofolate and its reduced derivatives against methotrexate-insensitive tumors.
    Mishra LC; Mead JA
    Chemotherapy; 1972; 17(4):283-92. PubMed ID: 4504773
    [No Abstract]   [Full Text] [Related]  

  • 25. Analog specific aberrancies in antifolate inhibition of L1210 cell dihydrofolate reductase.
    Sirotnak FM; Chello PL; Moccio DM; Piper JR; Montgomery JA; Parham JC
    Biochem Pharmacol; 1980 Dec; 29(24):3293-8. PubMed ID: 7213404
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of methotrexate on the intracellular nucleotide pools and its role in combination chemotherapy.
    Nobori T; Ochiai H; Shimizu N; Ohkubo T; Kawasaki H; Kamiya H; Sakurai M
    Adv Exp Med Biol; 1986; 195 Pt A():475-80. PubMed ID: 3728181
    [No Abstract]   [Full Text] [Related]  

  • 27. New approaches to chemotherapy.
    Hutchison DJ
    Ann N Y Acad Sci; 1971 Nov; 186():496-500. PubMed ID: 5002440
    [No Abstract]   [Full Text] [Related]  

  • 28. Antitumor efficacy of classical non-polyglutamylatable antifolates that inhibit dihydrofolate reductase.
    Abraham A; Nair MG; McGuire JJ; Galivan J; Kisliuk RL; Vishnuvajjala BR
    Adv Exp Med Biol; 1993; 338():663-6. PubMed ID: 8304202
    [No Abstract]   [Full Text] [Related]  

  • 29. Methotrexate analogs. 2. A facile method of preparation of lipophilic derivatives of methotrexate and 3',5'-dichloromethotrexate by direct esterification.
    Rosowsky A
    J Med Chem; 1973 Oct; 16(10):1190-3. PubMed ID: 4201424
    [No Abstract]   [Full Text] [Related]  

  • 30. Improved purification of tetrahydrofolate dehydrogenase from L1210 leukemia by affinity chromatography.
    Chello PL; Cashmore AR; Jacobs SA; Bertino JR
    Biochim Biophys Acta; 1972 Apr; 268(1):30-4. PubMed ID: 5018279
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of dihydrofolate reductase, methotrexate transport, and growth of methotrexate-sensitive and -resistant L1210 leukemia cells in vitro by 5-substituted 2,4-diaminoquinazolines.
    Susten SS; Hynes JB; Kumar A; Freisheim JH
    Biochem Pharmacol; 1985 Jun; 34(12):2163-7. PubMed ID: 4004934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline.
    Wroblewski DH; Bhushan A; Xuan Y; Brinton BT; Tritton TR; Hacker MP
    Cancer Chemother Pharmacol; 1996; 37(4):337-42. PubMed ID: 8548879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination chemotherapy with folate antagonists.
    Goldin A
    Ann N Y Acad Sci; 1971 Nov; 186():423-37. PubMed ID: 4944292
    [No Abstract]   [Full Text] [Related]  

  • 34. Preferential selection during therapy in vivo by edatrexate compared to methotrexate of resistant L1210 cell variants with decreased folylpolyglutamate synthetase activity.
    Rumberger BG; Schmid FA; Otter GM; Sirotnak FM
    Cancer Commun; 1990; 2(9):305-10. PubMed ID: 2206778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of resistance to methotrexate in L1210 murine leukemia by uracil.
    Wallerstein H; Slater LM; Eng B; Calman N
    Blood; 1971 Nov; 38(5):648-56. PubMed ID: 5094586
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
    [No Abstract]   [Full Text] [Related]  

  • 37. Reactivation of dihydrofolate reductase inhibted by methotrexate or aminopterin.
    Jackson RC; Niethammer D; Hart LI
    Arch Biochem Biophys; 1977 Aug; 182(2):646-56. PubMed ID: 561567
    [No Abstract]   [Full Text] [Related]  

  • 38. The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.
    Kline I; Venditti JM; Mead JA; Tyrer DD; Goldin A
    Cancer Res; 1966 May; 26(5):848-52. PubMed ID: 5934795
    [No Abstract]   [Full Text] [Related]  

  • 39. Folic acid analogs. II. p-[(2,6-Diamino-8-purinyl)methyl]amino-benzoyl-L-glutamic acid and related compounds.
    Weinstock LT; Grabowski BF; Cheng CC
    J Med Chem; 1970 Sep; 13(5):995-7. PubMed ID: 5458404
    [No Abstract]   [Full Text] [Related]  

  • 40. Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies.
    Rosowsky A; Forsch RA; Galivan J; Susten SS; Freisheim JH
    Mol Pharmacol; 1985 Jan; 27(1):141-7. PubMed ID: 3965926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.